Ambrus R - Search Results

1

Exploring Vacuum Compression Molding as a Preparation Method for Flexible-Dose Pediatric Orodispersible Films.

Hales D, Bogdan C, Tefas LR, Cornilă A, Chiver MA, Tomuță I, Casian T, Iovanov R, Katona G, Ambrus R, Iurian S. Hales D, et al. Among authors: ambrus r. Pharmaceuticals (Basel). 2024 Jul 12;17(7):934. doi: 10.3390/ph17070934. Pharmaceuticals (Basel). 2024. PMID: 39065784 Free PMC article.

2

[Investigation of permeability of intranasal formulations using Side-Bi-Side horizontal diffusion cell].

Horváth Tamás, Ambrus R, Szabóné RP. Horváth Tamás, et al. Among authors: ambrus r. Acta Pharm Hung. 2015;85(1):19-28. Acta Pharm Hung. 2015. PMID: 26137783 Hungarian.

3

The Effect of an Optimized Wet Milling Technology on the Crystallinity, Morphology and Dissolution Properties of Micro- and Nanonized Meloxicam.

Bartos C, Szabó-Révész P, Bartos C, Katona G, Jójárt-Laczkovich O, Ambrus R. Bartos C, et al. Among authors: ambrus r. Molecules. 2016 Apr 21;21(4):507. doi: 10.3390/molecules21040507. Molecules. 2016. PMID: 27110752 Free PMC article.

4

Development of oral lyophilisates containing meloxicam nanocrystals using QbD approach.

Iurian S, Bogdan C, Tomuță I, Szabó-Révész P, Chvatal A, Leucuța SE, Moldovan M, Ambrus R. Iurian S, et al. Among authors: ambrus r. Eur J Pharm Sci. 2017 Jun 15;104:356-365. doi: 10.1016/j.ejps.2017.04.011. Epub 2017 Apr 20. Eur J Pharm Sci. 2017. PMID: 28435075

5

Preliminary study of nanonized lamotrigine containing products for nasal powder formulation.

Gieszinger P, Csóka I, Pallagi E, Katona G, Jójárt-Laczkovich O, Szabó-Révész P, Ambrus R. Gieszinger P, et al. Among authors: ambrus r. Drug Des Devel Ther. 2017 Aug 23;11:2453-2466. doi: 10.2147/DDDT.S138559. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28860716 Free PMC article.

6

Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride.

Karimi K, Katona G, Csóka I, Ambrus R. Karimi K, et al. Among authors: ambrus r. J Pharm Biomed Anal. 2018 Jan 30;148:73-79. doi: 10.1016/j.jpba.2017.09.019. Epub 2017 Sep 22. J Pharm Biomed Anal. 2018. PMID: 28965047

7

Definition and validation of the Design Space for co-milled nasal powder containing nanosized lamotrigine.

Gieszinger P, Tomuta I, Casian T, Bartos C, Szabó-Révész P, Ambrus R. Gieszinger P, et al. Among authors: ambrus r. Drug Dev Ind Pharm. 2018 Oct;44(10):1622-1630. doi: 10.1080/03639045.2018.1483388. Epub 2018 Jul 2. Drug Dev Ind Pharm. 2018. PMID: 29863907 Free article.

8

Design and characterization of loratadine nanosuspension prepared by ultrasonic-assisted precipitation.

Alshweiat A, Katona G, Csóka I, Ambrus R. Alshweiat A, et al. Among authors: ambrus r. Eur J Pharm Sci. 2018 Sep 15;122:94-104. doi: 10.1016/j.ejps.2018.06.010. Epub 2018 Jun 14. Eur J Pharm Sci. 2018. PMID: 29908301

9

Optimization of a combined wet milling process in order to produce poly(vinyl alcohol) stabilized nanosuspension.

Bartos C, Jójárt-Laczkovich O, Katona G, Budai-Szűcs M, Ambrus R, Bocsik A, Gróf I, Deli MA, Szabó-Révész P. Bartos C, et al. Among authors: ambrus r. Drug Des Devel Ther. 2018 May 31;12:1567-1580. doi: 10.2147/DDDT.S159965. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 29910603 Free PMC article.

10

Formulation of levodopa containing dry powder for nasal delivery applying the quality-by-design approach.

Bartos C, Pallagi E, Szabó-Révész P, Ambrus R, Katona G, Kiss T, Rahimi M, Csóka I. Bartos C, et al. Among authors: ambrus r. Eur J Pharm Sci. 2018 Oct 15;123:475-483. doi: 10.1016/j.ejps.2018.07.061. Epub 2018 Aug 1. Eur J Pharm Sci. 2018. PMID: 30076956

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters